App-Quantinova.ai

EFFICACY OF HYDROXYCHLOROQUINE THERAPY ON WHOLE SALIVARY COMPONENTS IN PATIENTS WITH PRIMARY Sjogren's Syndrome

S. Corvaglia - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Dental and Oral Health

Sjogren's syndrome

Hydroxychloroquine

GLYCOGEN STORAGE DISEASE INDUCED RESTRICTIVE CARDIOMYOPATHY

Pratik Patel - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Restrictive cardiomyopathy

Hydroxychloroquine

ACUTE DECOMPENSATED HEART FAILURE: RARE INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

Priya Rajagopalan - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute decompensated heart failure

Hydroxychloroquine

NON-BACTERIAL THROMBOTIC ENDOCARDITIS IN A PATIENT WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME

Soumya Patnaik - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Nonbacterial thrombotic endocarditis

Hydroxychloroquine

HYDROXYCHLOROQUINE OVERDOSE PRESENTING AS ACQUIRED QT INTERVAL PROLONGATION AND TORSADE DE POINTES

Ifesinachi Ndukwu - American College of Cardiology (ACC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

A RARE CAUSE OF MYOCARDIAL INJURY IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: HYDROXYCHLOROQUINE INDUCED CARDIOMYOPATHY

Shakil Shaikh - American College of Cardiology (ACC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

A POPULATION-BASED STUDY ON MORTALITY AND THE INFLUENCE OF MEDICATION USE IN 4356 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 21845 MATCHED CONTROLS FROM THE UNITED KINGDOM

I.E. Bultink - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

ADALIMUMAB IN COMBINATION WITH NON-METHOTREXATE CONVENTIONAL SYNTHETIC DISEASE MODIFYING RHEUMATIC DRUGS IN A CLINICAL TRIAL SETTING

E.C. Keystone - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Hydroxychloroquine

ADDITIVE INHIBITION OF INTERFERONS, B AND T CELL ACTIVATION AND TFH-RELATED CYTOKINE CXCL13 BY LEFLUNOMIDE AND HYDROXYCHLOROQUINE SUPPORTS RATIONALE FOR COMBINATION THERAPY IN PSS PATIENTS

E.H. van der Heijden - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

ANALYSIS OF THE TREATMENT EFFICACY FOR RETROPERITONEAL FIBROSIS - A CASE SERIES. SUSPICION OF ERDHEIM-CHESTER DISEASE IN A PATIENT WITH AN INITIAL DIAGNOSIS OF RETROPERITONEAL FIBROSIS, REFRACTORY TO STANDARD TREATMENT

J. Koblowski - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydroxychloroquine

ARTESUNATE CAN INHIBIT MIGRATION AND INVASION OF FIBROBLAST-LIKE SYNOVIOCYTES VIA SUPPRESSION OF MATRIX METALLOPROTEINASE 9 IN RHEUMATOID ARTHRITIS PATIENTS

J. Jing - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

Hydroxychloroquine

ASSOCIATION BETWEEN SAFETY, EFFICACY AND HYDROXYCHLOROQUINE DOSAGE IN THE TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS

R. Wakiya - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

BIOLOGICS AND OTHER INFLAMMATORY THERAPIES IN FINGER OA. WHAT HAVE WE LEARNED?

X. Chevalier - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Hydroxychloroquine

COMPARATIVE EFFECTIVENESS OF FIRST-LINE BIOLOGIC MONOTHERAPY IN RHEUMATOID ARTHRITIS

E. Silvagni - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

EFFECT OF METHOTREXATE, LEFLUNOMIDE AND HYDROXYCHLOROQUINE ON THE INSULIN RESISTANCE AND OBESITY ASSOCIATED WITH RHEUMATOID ARTHRITIS: OBESE MOUSE MODELS OF RHEUMATOID ARTHRITIS

I. Arias de la Rosa - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

FOREPLAY AND FINALE: FACTORS AFFECTING FERTILITY, BIRTH AND LACTATION IN RHEUMATOID ARTHRITIS PATIENTS. CLINICAL CASE

P. Nero - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

FURTHER TREATMENT INTENSIFICATIONS IN UNDIFFERENTIATED AND RHEUMATOID ARTHRITIS PATIENTS ALREADY IN LOW DISEASE ACTIVITY HAVE LIMITED BENEFIT TOWARDS PHYSICAL FUNCTIONING

S.A. Bergstra - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB

R. Talotta - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

METABOLIC AND CARDIO-VASCULAR BENEFITS OF HYDROXYCHLOROQUINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

C. Rempenault - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVEL IN PATIENTS WITH UNTREATED SYSTEMIC LUPUS ERYTHEMATOSUS

T. Panafidina - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Filters

1151 Abstracts